US Patent 9108934 Neprilysin inhibitors
Patent 9108934 was granted and assigned to Theravance on August, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+88 characters)
Article
Patent abstract
In one aspect, the invention relates to compounds having the formula XII:
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09108934 Neprilysin inhibitors US Patent 9108934 Neprilysin inhibitors
Infobox
Patent Number
091089340
Patent Number
91089340
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
091089340
Date of Patent
August 18, 2015
0Patent Application Number
139118190
Date Filed
June 6, 2013
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09108934 Neprilysin inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09108934
Date of patent
August 18, 2015
Patent application number
13911819
Date Filed
June 6, 2013
Patent primary examiner
Find more entities like US Patent 9108934 Neprilysin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
